PTC Therapeutics, Inc. (PTCT)
USD 49.95
(0.87%)
USD 49.95
(0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 937.82 Million | 698.8 Million | 538.59 Million | 380.76 Million | 306.98 Million | 264.73 Million |
| Cost of Revenue | 65.48 Million | 44.67 Million | 32.32 Million | 18.94 Million | 12.13 Million | 12.67 Million |
| Gross Profit | 872.33 Million | 654.12 Million | 506.26 Million | 361.82 Million | 294.84 Million | 252.06 Million |
| Operating Expenses | 1.31 Billion | 1.09 Billion | 881.2 Million | 759.69 Million | 487.64 Million | 348.4 Million |
| Selling, General and Administrative Expenses | 332.54 Million | 325.99 Million | 285.77 Million | 245.16 Million | 202.54 Million | 153.54 Million |
| Research and Development Expenses | 666.56 Million | 651.49 Million | 540.68 Million | 477.64 Million | 257.45 Million | 171.98 Million |
| Other Expenses | - | 116.55 Million | 54.75 Million | 36.89 Million | 27.65 Million | 129 Thousand |
| Cost and Expenses | 1.28 Billion | 1.13 Billion | 913.53 Million | 778.64 Million | 499.77 Million | 361.07 Million |
| Operating Income | -349.4 Million | -439.92 Million | -374.94 Million | -397.87 Million | -192.79 Million | -115.68 Million |
| Interest Expense | 129.18 Million | 90.87 Million | 86.02 Million | 56.35 Million | 12.49 Million | 12.55 Million |
| Income Tax Expense | -69.5 Million | -28.47 Million | 5.56 Million | 35.22 Million | 11.65 Million | -29 Thousand |
| Earnings before Tax | -696.11 Million | -587.48 Million | -518.34 Million | -402.93 Million | -239.92 Million | -128.11 Million |
| Net Income | -626.6 Million | -559.01 Million | -523.9 Million | -438.16 Million | -251.57 Million | -128.08 Million |
| Earnings Per Share Basic | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 |
| Earnings Per Share Diluted | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 |
| Weighted Average Shares Outstanding | 74.83 Million | 71.72 Million | 70.46 Million | 66.02 Million | 58.86 Million | 46.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.83 Million | 71.72 Million | 70.46 Million | 66.02 Million | 58.86 Million | 46.57 Million |
| Gross Margin | 0.93 | 0.94 | 0.94 | 0.95 | 0.96 | 0.95 |
| EBIT Margin | -0.35 | -0.53 | -0.70 | -0.60 | -0.38 | -0.20 |
| Profit Margin | -0.67 | -0.80 | -0.97 | -1.15 | -0.82 | -0.48 |
| EBITDA | -330.34 Million | -367.78 Million | -374.44 Million | -297 Million | -191.37 Million | -89.46 Million |
| Earnings Before Tax Margin | -0.37 | -0.63 | -0.70 | -1.04 | -0.63 | -0.44 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 186.7 Million | 210.11 Million | 307.05 Million | 937.82 Million | 196.57 Million | 213.8 Million |
| Cost of Revenue | 18.39 Million | 66.26 Million | 106.29 Million | 288.12 Million | 9.49 Million | 12.73 Million |
| Gross Profit | 168.31 Million | 143.84 Million | 200.76 Million | 649.7 Million | 187.08 Million | 201.07 Million |
| Operating Expenses | 201.66 Million | 189.4 Million | 197.64 Million | 999.1 Million | 305.24 Million | 321.72 Million |
| Selling, General and Administrative Expenses | 69.5 Million | 73.27 Million | 76.29 Million | - | 80.88 Million | 88.44 Million |
| Research and Development Expenses | 132.16 Million | 116.12 Million | 121.35 Million | - | 164.21 Million | 185.87 Million |
| Other Expenses | -2.02 Million | 1.59 Million | 18.96 Million | 10.13 Million | 60.14 Million | 1.47 Million |
| Cost and Expenses | 220.06 Million | 255.67 Million | 303.93 Million | 1.28 Billion | 314.74 Million | 334.45 Million |
| Operating Income | -33.35 Million | -45.55 Million | 3.12 Million | -349.4 Million | -118.16 Million | -209.54 Million |
| Interest Expense | 43.49 Million | 40.83 Million | 44.27 Million | 129.18 Million | -28.16 Million | 29.41 Million |
| Income Tax Expense | 13.44 Million | 6.88 Million | -1.25 Million | -69.5 Million | -33.62 Million | -38.59 Million |
| Earnings before Tax | -85.73 Million | -84.69 Million | -157.05 Million | -696.11 Million | -166.59 Million | -237.47 Million |
| Net Income | -99.17 Million | -91.57 Million | -155.79 Million | -626.6 Million | -132.97 Million | -198.88 Million |
| Earnings Per Share Basic | -1.29 | -1.20 | -2.06 | - | -1.76 | -2.66 |
| Earnings Per Share Diluted | -1.29 | -1.20 | -2.06 | - | -1.76 | -2.66 |
| Weighted Average Shares Outstanding | 76.72 Million | 76.49 Million | 75.51 Million | 74.83 Million | 75.37 Million | 74.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 76.72 Million | 76.49 Million | 75.51 Million | 74.83 Million | 75.37 Million | 74.73 Million |
| Gross Margin | 0.90 | 0.68 | 0.65 | 0.69 | 0.95 | 0.94 |
| EBIT Margin | -0.14 | 0.05 | 0.27 | - | -0.60 | -0.32 |
| Profit Margin | -0.53 | -0.44 | -0.51 | -0.67 | -0.68 | -0.93 |
| EBITDA | -26.33 Million | 9.84 Million | 83.82 Million | - | -118.16 Million | -68.15 Million |
| Earnings Before Tax Margin | -0.18 | -0.22 | 0.01 | -0.37 | -0.60 | -0.98 |
PMMEF
ARR
TOTS3
EDELWEISS
EUUNF
IQV